157 related articles for article (PubMed ID: 19502615)
1. A novel approach to cancer staging: application to esophageal cancer.
Ishwaran H; Blackstone EH; Apperson-Hansen C; Rice TW
Biostatistics; 2009 Oct; 10(4):603-20. PubMed ID: 19502615
[TBL] [Abstract][Full Text] [Related]
2. Influence of the number of malignant regional lymph nodes detected by endoscopic ultrasonography on survival stratification in esophageal adenocarcinoma.
Chen J; Xu R; Hunt GC; Krinsky ML; Savides TJ
Clin Gastroenterol Hepatol; 2006 May; 4(5):573-9. PubMed ID: 16630763
[TBL] [Abstract][Full Text] [Related]
3. Can extracapsular lymph node involvement be a tool to fine-tune pN1 for adenocarcinoma of the oesophagus and gastro-oesophageal junction in the Union Internationale contre le Cancer (UICC) TNM 7th edition?†.
Nafteux P; Lerut T; De Hertogh G; Moons J; Coosemans W; Decker G; Van Veer H; De Leyn P
Eur J Cardiothorac Surg; 2014 Jun; 45(6):1001-10. PubMed ID: 24477743
[TBL] [Abstract][Full Text] [Related]
4. Lymphovascular invasion as a tool to further subclassify T1b esophageal adenocarcinoma.
Cen P; Hofstetter WL; Correa AM; Wu TT; Lee JH; Ross WA; Davilla M; Swisher SG; Fukami N; Rashid A; Maru D; Ajani JA
Cancer; 2008 Mar; 112(5):1020-7. PubMed ID: 18205187
[TBL] [Abstract][Full Text] [Related]
5. Application of Pathological Staging in Esophageal Adenocarcinoma.
Lam AK
Methods Mol Biol; 2018; 1756():93-103. PubMed ID: 29600363
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the 6th and 7th Editions of the UICC-AJCC TNM Classification for Esophageal Cancer.
Talsma K; van Hagen P; Grotenhuis BA; Steyerberg EW; Tilanus HW; van Lanschot JJ; Wijnhoven BP
Ann Surg Oncol; 2012 Jul; 19(7):2142-8. PubMed ID: 22395974
[TBL] [Abstract][Full Text] [Related]
7. [Understanding and appraisal of the new TNM classification for esophageal cancer in the AJCC Cancer Staging Manual (7th edition)].
Chen LQ
Zhonghua Zhong Liu Za Zhi; 2010 Mar; 32(3):237-40. PubMed ID: 20450597
[No Abstract] [Full Text] [Related]
8. Comparison between established and the Worldwide Esophageal Cancer Collaboration staging systems.
Gaur P; Hofstetter WL; Bekele BN; Correa AM; Mehran RJ; Rice DC; Roth JA; Vaporciyan AA; Rice TW; Swisher SG
Ann Thorac Surg; 2010 Jun; 89(6):1797-1803, 1804.e1-3; discussion 1803-4. PubMed ID: 20494031
[TBL] [Abstract][Full Text] [Related]
9. Predictors of Nodal Metastases for Clinical T2N0 Esophageal Adenocarcinoma.
Barbetta A; Schlottmann F; Nobel T; Sewell DB; Hsu M; Tan KS; Gerdes H; Shah P; Bains MS; Bott M; Isbell JM; Jones DR; Molena D
Ann Thorac Surg; 2018 Jul; 106(1):172-177. PubMed ID: 29627387
[TBL] [Abstract][Full Text] [Related]
10. Should the esophageal cancer staging system be revised?
Rusch VW
J Thorac Cardiovasc Surg; 2003 May; 125(5):992-3. PubMed ID: 12771870
[No Abstract] [Full Text] [Related]
11. Staging of adenocarcinoma of the esophagogastric junction: comparison of AJCC 6th and 7th gastric and 7th esophageal staging systems.
Kim HI; Cheong JH; Song KJ; An JY; Hyung WJ; Noh SH; Kim CB
Ann Surg Oncol; 2013 Aug; 20(8):2713-20. PubMed ID: 23456315
[TBL] [Abstract][Full Text] [Related]
12. Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Cancer Staging Manuals.
Rice TW; Rusch VW; Ishwaran H; Blackstone EH;
Cancer; 2010 Aug; 116(16):3763-73. PubMed ID: 20564099
[TBL] [Abstract][Full Text] [Related]
13. Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification.
Schneider PM; Baldus SE; Metzger R; Kocher M; Bongartz R; Bollschweiler E; Schaefer H; Thiele J; Dienes HP; Mueller RP; Hoelscher AH
Ann Surg; 2005 Nov; 242(5):684-92. PubMed ID: 16244542
[TBL] [Abstract][Full Text] [Related]
14. Total number of resected lymph nodes predicts survival in esophageal cancer.
Altorki NK; Zhou XK; Stiles B; Port JL; Paul S; Lee PC; Mazumdar M
Ann Surg; 2008 Aug; 248(2):221-6. PubMed ID: 18650631
[TBL] [Abstract][Full Text] [Related]
15. Prognosis of early esophageal cancer: differences between squamous cell carcinoma and adenocarcinoma.
Bollschweiler E; Hölscher AH
Ann Surg; 2007 Feb; 245(2):334. PubMed ID: 17245190
[No Abstract] [Full Text] [Related]
16. The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma.
Incarbone R; Bonavina L
Cancer; 1999 Nov; 86(9):1883-5. PubMed ID: 10547564
[No Abstract] [Full Text] [Related]
17. [Preoperative neoadjuvant chemotherapy in esophago-cardial adenocarcinoma?].
Geissler M
Dtsch Med Wochenschr; 2006 Jun; 131(23):1344. PubMed ID: 16761207
[No Abstract] [Full Text] [Related]
18. Location of lymph node involvement in patients with esophageal adenocarcinoma predicts survival.
Talsma AK; Ong CA; Liu X; van Hagen P; Van Lanschot JJ; Tilanus HW; Hardwick RH; Carroll NR; Spaander MC; Fitzgerald RC; Wijnhoven BP
World J Surg; 2014 Jan; 38(1):106-13. PubMed ID: 24101018
[TBL] [Abstract][Full Text] [Related]
19. Factors predicting survival in patients with proximal gastric carcinoma involving the esophagus.
Zhang YF; Shi J; Yu HP; Feng AN; Fan XS; Lauwers GY; Mashimo H; Gold JS; Chen G; Huang Q
World J Gastroenterol; 2012 Jul; 18(27):3602-9. PubMed ID: 22826627
[TBL] [Abstract][Full Text] [Related]
20. Computed tomographic staging of esophageal cancer and prognosis.
Ampil FL; Caldito G; Li BD; Pelser R
Radiat Med; 2001; 19(3):127-9. PubMed ID: 11467379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
